How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

What it is about

Who published it, and when

How it spread - 146 original reports, 10 reprints

1. Wed, 5 August 2026

   1 report
   • Google News - Europe query16:52first to report
     How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

     How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy? MarketWatch

2. Thu, 6 August 2026

   2 reports
   • Google News - Top Stories13:45
     The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings

     The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings CNBC Lilly climbs, Novo falls as obesity drug battle intensifies BioPharma Dive How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy? MarketWatch Lilly confident in slow and steady Foundayo launch, as ex-US sales shine BioSpace Lilly’s obesity pill Foundayo ‘disappointed’ in Q2, as injectables continue to boom Fierce Pharma

   • Google News - Top Stories13:45
     The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings

     The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings CNBC Lilly climbs, Novo falls as obesity drug battle intensifies BioPharma Dive Lilly confident in slow and steady Foundayo launch, as ex-US sales shine BioSpace How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy? MarketWatch Novo takes another shot at Lilly The Economist

3. Mon, 10 August 2026

   1 report
   • foreignpolicyjournal.com00:24
     Eli Lilly (NYSE: LLY) Files For Next-Gen Weight-Loss Drug Retatrutide In Q1 2027, Leaving Novo Nordisk (NYSE: NVO) Scrambling

     Eli Lilly (NYSE: LLY) has officially confirmed it will submit a Biologics License Application to the U.S. Food and Drug Administration for retatrutide in the

4. Tue, 11 August 2026

   1 report
   • bakeryandsnacks.com00:00
     The hunger switch Ozempic doesn’t actually turn off

     A new Yale study challenges what we thought we knew about how Ozempic and other GLP-1 drugs sustain weight loss – here's what the science means for food manufacturers.

5. Wed, 12 August 2026

   1 report
   • The Hill16:19
     Eli Lilly targets alleged black market sales of its experimental GLP-1 drug

     Eli Lilly is suing six entities that it alleges are selling black market versions of its experimental weight-loss drug retatrutide. Lilly's lawsuits target U.S. entities selling illegal retatrutide products, including compounding pharmacies, medical spas and online sellers that sell retatrutide as a weight-loss "hack." Those entities falsely claim their drugs are for “research-use only” when...

6. Thu, 13 August 2026

   2 reports
   • wkbw.com14:41
     GLP-1 drugs are booming in 2026 — here's how to find a safe telehealth provider

     GLP-1 drugs like Ozempic are booming. Experts share red flags and tips for finding a safe telehealth provider.

   • Le Figaro (France)17:23
     Labos européens, américains, chinois… La bataille mondiale des traitements contre l’obésité fait rage

     DÉCRYPTAGE - Ce marché très prometteur, mais aujourd’hui aux mains du duopole Novo Nordisk-Eli Lilly, aiguise les appétits. Les acteurs du monde entier se lancent dans la course.

7. Sat, 15 August 2026

   2 reports
   • Google News - Top Stories02:04
     GLP-1s May Be Working in an Entirely Different Way Than We Thought

     GLP-1s May Be Working in an Entirely Different Way Than We Thought ScienceAlert Scientists solve the mystery of a brain “switch” that can trigger weight loss in opposite ways ScienceDaily New study may change how we think about GLP-1s YaleNews GLP-1 obesity drugs activate hunger neurons to drive fat loss 동아사이언스 New Weight Loss Pills Barely Worked in Mice Until Scientists Uncovered a Brain Circuit Controlling Cravings Medical Daily

   • Index.hr (Croatia)20:17
     "Neuroni gladi" imaju neočekivanu ulogu u djelovanju Ozempica, pokazala studija

     NOVA studija otkriva da Ozempic djeluje i putem "neurona gladi" koji potiču tijelo na aktivnije trošenje masnih zaliha i dugoročno mršavljenje.

8. Sun, 16 August 2026

   1 report
   • derstandard.at16:30
     The brain may be about to have its Ozempic moment

     Pharma’s newest obsession involves mimicking the system that keeps people awake

9. Mon, 17 August 2026

   1 report
   • news24.com15:24
     Nestlé plans new products to manage ‘Ozempic face’ and other weight loss side effects

     Nestlé is looking to turn the rise of GLP-1 weight loss drugs from a threat into a business opportunity, using AI and nutritional science to develop products for millions of consumers taking medicines such as Ozempic and Wegovy.

10. Tue, 18 August 2026

    3 reports
    • foodmanufacture.co.uk00:00
      What do consumers call GLP-1s?

      When consumers talk about GLP-1s, what do they call them? Do they use brand names like Ozempic and Mounjaro, shorthands like 'fat jabs,' or the clinical term itself?

    • confectionerynews.com00:00
      Nestlé bets big on GLP-1s with AI-powered nutrition push

      Nestlé is developing products tailored to GLP-1 users, using AI and nutritional science to address challenges including muscle loss, dehydration and rebound hunger, as the food giant positions itself for the growing weight-loss drug market.

    • fool.com23:10
      Why Amylyx Pharmaceuticals Stock Skyrocketed Today

      GLP-1 drugs aren't just for weight loss.

11. Wed, 19 August 2026

    3 reports
    • longislandpress.com18:48
      Weight Loss Today: GLP-1 Medications & Supplements Explained

      Learn from Dr. Rebecca Fishman, physician at Catholic Health, about how GLP-1 medications support weight loss, available weight loss supplements, and gain

    • El Mundo (Spain)22:13
      El mayor reto de las grandes compañías alimentarias: la gente que ya no quiere comer

      Con los fármacos GLP-1 amenazando miles de millones de dólares en ventas, los fabricantes de alimentos envasados están probando formas de ganarse a quienes ya no tienen tanto apetito Leer

    • El Mundo (Spain)22:16edited after publishing
      El fenómeno de la berberina: ¿realmente funciona como un Ozempic natural o hay exageración?

      previously¿Es exagerado llamar a la berberina el Ozempic natural?

      Es uno de los suplementos más respaldados por la ciencia para el control glucémico pero, ¿realmente la berberina funciona como un medicamento análogo de GLP-1 o hay exageración y mucho marketing? Leer

12. Thu, 20 August 2026

    4 reports
    • Google News - Top Stories12:53
      Wegovy and Zepbound are changing how Americans get health care

      Wegovy and Zepbound are changing how Americans get health care USA Today GLP-1s are forcing a strategic reset across healthcare: Wells Fargo report Fierce Healthcare Researchers find new benefits, risks in GLP-1 weight loss drugs WAFB How GLP-1 weight loss drugs are reshaping the healthcare industry Fox Business Scientists Are Discovering Unexpected Benefits of GLP-1 Drugs SciTechDaily

    • Google News - Top Stories13:05
      How GLP-1 weight loss drugs are reshaping the healthcare industry

      How GLP-1 weight loss drugs are reshaping the healthcare industry Fox Business Wegovy and Zepbound are changing how Americans get health care USA Today Researchers find new benefits, risks in GLP-1 weight loss drugs WAFB Scientists Are Discovering Unexpected Benefits of GLP-1 Drugs SciTechDaily Beyond GLP-1s: Combination Therapy, New Hormones Reshape Obesity Treatment Yale Medicine

    • yahoo.com21:05
      There’s a Black Market for Eli Lilly’s Unapproved GLP-1 Drug. Here’s Why That’s Bullish

      Can anyone challenge Eli Lilly in the weight loss space?

    • ABC (Spain)22:45edited after publishing
      La pastilla que adelgaza e imita los beneficios del ejercicio

      previouslyPost-Ozempic: una pastilla que adelgaza e imita los beneficios del ejercicio

      Durante décadas, adelgazar con un tratamiento parecía más una promesa que una realidad, casi como la ilusión que se vendía con las cremas antiedad. Hasta que llegaron Ozempic y otros medicamentos de la familia GLP-1. El mundo ahora se divide entre los que pierden peso con un pinchazo y los que siguen esforzándose con dieta y ejercicio. Pero si conoce a alguien en tratamiento, sabrá que perder peso con estos fármacos tampoco es tan sencillo. Muchos abandonan la medicación por sus efectos...

13. Fri, 21 August 2026

    2 reports
    • Times of India04:57edited after publishing
      Lip plumpers, collagen & more: How Ozempic is boosting a new beauty market

      previouslyLip plumpers, collagen and more: How is Ozempic boosting a new beauty market

      Weight-loss drugs are creating new demands in beauty and nutrition sectors. Companies are developing products to address nutritional gaps and emerging beauty concerns. Nestle and Tata Consumer are preparing protein and fiber-rich offerings for these consumers. Beauty brands are promoting makeup alternatives to cosmetic procedures for users. This trend is driven by pharmaceutical advancements and growing patient bases.

    • wxyz.com15:03
      Researchers test GLP-1 medications as possible treatment for opioid addiction

      Vanderbilt researchers are studying whether GLP-1 drugs used for diabetes and obesity can help prevent opioid relapse.

      2 reprints

      • katc.com21 Aug, 15:03removed
      • wkbw.com21 Aug, 15:03their copy
14. Sat, 22 August 2026

    1 report
    • El País (Spain)03:30
      La personalidad Ozempic o cómo la delgadez extrema acaba con el placer: “Me arrebató mi habitual optimismo”

      Usuarios de medicamentos GLP-1 se sinceran en las redes sobre su anhedonia, un efecto secundario que les impide disfrutar o interesarse por las actividades que antes les resultaban gratificantes

15. Sun, 23 August 2026

    3 reports
    • DW Top Stories09:20
      Is the US seeing a turning point in obesity rates?

      Obesity rates climbed in the US for years, but now there are signs this could be changing. Use of weight-loss drugs such as Ozempic and Wegovy has increased rapidly — are they helping?

    • juneauempire.com15:30
      MY TURN: The biological prescription schools are ignoring

      In the ongoing debate surrounding America’s metabolic crisis, we have reached a bizarre cultural paradox. On one side, we are witnessing the medicalization of appetite: millions of adults are turning to GLP-1 receptor agonists like Ozempic and Wegovy to synthetically force their bodies into feeling full. On the other, public health dialogue remains stubbornly fixated on lecturing individuals about willpower.

    • sbs.com.au19:48edited after publishing
      The hidden underbelly of Australia's weight-loss drug boom

      Below the surface of Australia's weight-loss drug boom, a market operates outside the prescription system.

16. Mon, 24 August 2026

    6 reports
    • sci.news17:31
      Researchers Revive Decades-Old Drug to Fight Obesity

      Scientists have identified a decades-old chemical compound as a promising new candidate for treating obesity and related metabolic diseases.

    • The Hill18:53
      Unexpected GLP-1 side effect? Studies show the meds may help people with addictions

      From unexpected babies to "Ozempic teeth," the ultra-popular class of GLP-1 medications are turning out to have a few unanticipated side effects. Emerging research shows the drugs, which have proven effective in treating obesity and diabetes, may also be useful in treating addiction.

    • iheart.com20:04
      GLP-1 Medications Could Treat Addiction

      GLP-1 medications, like Ozempic and Wegovy, may treat addiction by reducing cravings. A study shows they lower the risk of substance use disorders and severe harm. Researchers suggest clinical trials to explore this potential further.

    • iheart.com20:04
      GLP-1 Medications Could Treat Addiction

      GLP-1 medications, like Ozempic and Wegovy, may treat addiction by reducing cravings. A study shows they lower the risk of substance use disorders and severe harm. Researchers suggest clinical trials to explore this potential further.

    • iheart.com20:04
      GLP-1 Medications Could Treat Addiction

      GLP-1 medications, like Ozempic and Wegovy, may treat addiction by reducing cravings. A study shows they lower the risk of substance use disorders and severe harm. Researchers suggest clinical trials to explore this potential further.

    • iheart.com20:04
      GLP-1 Medications Could Treat Addiction

      GLP-1 medications, like Ozempic and Wegovy, may treat addiction by reducing cravings. A study shows they lower the risk of substance use disorders and severe harm. Researchers suggest clinical trials to explore this potential further.

17. Tue, 25 August 2026

    5 reports
    • mykisscountry937.com09:19
      Doctors Confirm: Unplanned Side Effects When You Take GLP-1 Meds

      Several unpublished but very beneficial side effects appear to be connected to the use of those medications.

    • foxnews.com10:00
      GLP-1 boom could reshape restaurant bars as diners cut back on alcohol

      A new report reveals a growing interest in drink choices among restaurant customers. The report found that health is already influencing some Americans' decisions about alcohol.

    • Index.hr (Croatia)13:35
      Psilijum je novi hit za mršavljenje, no može li doista zamijeniti Ozempic?

      POPULARNOST lijekova za mršavljenje potaknula je potragu za jeftinijim i lako dostupnim alternativama.

    • fool.com19:18
      2 Stocks That Could Capitalize on the GLP-1 Boom

      They aren't the most prominent names in the GLP-1 space, but they are worth a second look.

    • fool.com19:18
      2 Stocks That Could Capitalize on the GLP-1 Boom

      They aren't the most prominent names in the GLP-1 space, but they are worth a second look.

18. Fri, 28 August 2026

    3 reports
    • aol.com11:00
      You'll Never Believe Where Weight Goes When You Lose It

      This is certainly enlightening.

    • Google News - Top Stories18:38
      US FDA approves Lilly's Mounjaro to reduce cardiovascular risk

      US FDA approves Lilly's Mounjaro to reduce cardiovascular risk Reuters Mounjaro Is Now Approved to Lower the Risk of Heart Events Time Magazine FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes Eli Lilly and Company Lilly Diabetes Shot Mounjaro Wins US Approval for Heart Disease Bloomberg.com Lilly scores Novo-pressuring Mounjaro expansion to curb heart risks in diabetes patients Fierce Pharma

    • time.com18:56
      Mounjaro Is Now Approved to Lower the Risk of Heart Events

      The new indication for Eli Lilly's drug is for people with Type 2 diabetes.

19. Sun, 30 August 2026

    2 reports
    • bworldonline.com16:04
      Beyond the scale: US men turn to cosmetic clinics to complete weight-loss transformation

      AS TOP-SELLING weight-loss drugs help more US men slim down, a growing number are seeking cosmetic treatments for sagging skin, hair loss, and dental issues to complete their physical transformation, patients and plastic surgeons say. Mark C., a 57-year-old from Hoboken, New Jersey, has spent the past five years taking obesity medications, first Novo Nordisk’s […]

    • edenmagnet.com.au20:00
      Weight drugs trigger 'cultural body trauma' for women

      The rise of GLP-1 medications for weight loss might have triggered another "cultural trauma" about women's bodies and...

      1 reprint

      • bluemountainsgazette.com.au30 Aug, 20:00their copy
20. Mon, 31 August 2026

    5 reports
    • ABC News (Australia)02:12
      GLP-1 drug prescribed to woman with eating disorder via telehealth

      The ABC has learned of a young woman with anorexia nervosa who was prescribed an Ozempic-like drug through a telehealth clinic. Experts say the incident highlights the need for more oversight.

    • forbes.com08:30
      Together, GLP-1s And GenAI Can Solve Healthcare’s Affordability Crisis

      Two innovations offer a new path to healthcare affordability: GLP-1 medications and generative AI. Here's how to two could radically improve medicine and lower costs.

    • theguardian.com12:00
      ‘Who knows what they’re taking?’: people risk the gray market for the newest weight-loss drug

      Retatrutide, not yet approved by the FDA, is the latest wonder drug to shed pounds despite warnings from doctors

    • Google News - Top Stories22:32
      GLP-1 weight loss drugs effective even at low starter doses

      GLP-1 weight loss drugs effective even at low starter doses Reuters Inappropriate use of GLP-1-based antiobesity medications: beyond appropriate drug use toward appropriate weight reduction | Diabetology International Springer Nature Link GLP-1 RAs produce significant weight loss in adults without diabetes, with newer treatments showing greater results Medical Xpress GLP-1s may have a host of other health benefits. Just ask these people usatoday.com Experts call for safer weight loss as...

    • yahoo.com22:43
      GLP-1s may work by activating an unlikely weight loss ally

      A neuron known for stimulating hunger is actually triggered into overdrive by semaglutide.

21. Tue, 1 September 2026

    4 reports
    • vendingmarketwatch.com00:00edited after publishing
      GLP-1 users shift toward protein-rich snacks and smaller meals

      previouslyGLP-1 food trends reshape snacking and small meal choices

    • Tagesschau (Germany)08:40
      Neue US-Studie: Verursachen Abnehmspritzen Haarausfall?

      Viele Diabetes-Medikamente werden auch bei starkem Übergewicht eingesetzt. Eine US-Studie zeigt nun: Bei GLP-1-Mitteln ist das Risiko für Haarausfall höher als bei anderen Medikamenten. Von Doris Tromballa.

    • The Hill10:10
      GLP-1s may work by activating an unlikely weight loss ally

      Unfortunately, testing hunger neurons in a living person isn't possible, but the study's authors hope their data can guide researchers toward new weight loss treatments.

    • El Mundo (Spain)20:42
      Ozempic ya se usa para tratar a adictos en España: "Bebía tres botellas por noche, ahora me vale con dos copas"

      Fernando estaba tan enganchado que llegó a caerse de un tercer piso y, aun así, siguió bebiendo. Ahora, un pinchazo semanal de un GLP-1 le ayuda a moderar su consumo. Es el primer español que cuenta su tratamiento de adicción con este fármaco, un abordaje que divide a los especialistas Leer

22. Wed, 2 September 2026

    4 reports
    • Il Fatto Quotidiano (Italy)11:50
      Boom di acquisti di farmaci dimagranti, l’allarme degli esperti: “Non sono una scorciatoia estetica, hanno effetti molto potenti ecco cosa si rischia ad usarli senza una diagnosi”

      Semaglutide e Tirzepatide stanno cambiando profondamente il trattamento del diabete di tipo 2 e dell’obesità. Ma proprio il loro successo terapeutico sta creando un equivoco: considerarli semplicemente come “farmaci dimagranti”. In realtà, quando vengono prescritti a un paziente con diabete o con obesità clinicamente significativa, siamo di fronte a terapie farmacologiche per patologie croniche, con […] L'articolo Boom di acquisti di farmaci dimagranti, l’allarme degli esperti: “Non sono una...

    • endocrinologyadvisor.com13:26
      GLP-1 Use Not Linked to Low Cup-to-Disc Ratio in Nonarteritic Optic Neuropathy

      Low cup-to-disc ratio is common in fellow eyes of patients with nonarteritic anterior ischemic optic neuropathy, regardless of GLP-1 RA use.

    • endocrinologyadvisor.com13:29
      Obesity Is Associated With Poorer Clinical Outcomes in Primary Aldosteronism

      For patients with obesity and primary aldosteronism, there is a link to a higher cardiometabolic burden and poorer clinical response to targeted treatments.

    • womenshealthmag.com15:16
      GLP-1s Are Praised for Silencing Food Noise. That's Not Always a Good Thing, According to Experts

      A dietitian explains what’s at stake.

23. Thu, 3 September 2026

    3 reports
    • Google News - Top Stories09:00
      GLP-1 medications may worsen or speed hair loss in some men, study finds

      GLP-1 medications may worsen or speed hair loss in some men, study finds NBC News Diabetic GLP-1 use linked to increased hair loss risk Penn Today Possible Side Effect for Men on GLP-1s: Baldness Newser Genes May Explain Hair Loss in Men on Wegovy, Ozempic Seoul Economic Daily Fat jabs like Wegovy or Mounjaro can spark hair loss in men, scientists warn The Sun

    • Google News - Top Stories13:04
      Possible Side Effect for Men on GLP-1s: Baldness

      Possible Side Effect for Men on GLP-1s: Baldness Newser Genes May Explain Hair Loss in Men on Wegovy, Ozempic Seoul Economic Daily Some Hair Loss in Men Is Linked to Use of Weight Loss Drugs morningstar.com Why Your Hair Might Be Thinning on a GLP-1 Drug—and What To Do About It Yahoo Health Diabetic GLP-1 use linked to increased hair loss risk Penn Medicine

    • phillyvoice.com20:42
      GLP-1 meds cause more hair loss than other drugs used to treat type 2 diabetes, Penn study finds

      This research provides evidence to a side effect that had been reported anecdotally.

24. Fri, 4 September 2026

    1 report
    • Slobodna Dalmacija (Croatia)11:17
      Popularni lijekovi za mršavljenje nisu za svakoga: poseban oprez nužan je ako imate neki od ovih probavnih problema

      Prije kombiniranja GLP-1 lijekova s postojećim probavnim tegobama važno je uzeti u obzir moguće rizike i nuspojave. GLP-1 lijekovi propisuju se za snižavanje razine šećera u krvi kod osoba s dijabetesom tipa 2, ali i za regulaciju tjelesne težine kod osoba s pretilošću. U ovu skupinu lijekova pripad...

25. Mon, 7 September 2026

    1 report
    • Il Fatto Quotidiano (Italy)11:56
      “Prima era solo un sospetto, ora c’è la conferma. Ozempic, Wegovy e i farmaci dimagranti aumentano la perdita dei capelli, soprattutto negli uomini già predisposti all’alopecia”: il nuovo studio

      Nuova luce su uno dei più temuto effetti collaterali dei nuovi farmaci anti-obesità, i GLP-1 come Ozempic, Wegovy e Zepbound: la perdita dei capelli. Se finora il diradamento della chioma veniva attribuito unicamente al rapido calo ponderale legato all’uso di queste molecole, una ricerca condotta dalla NYU Langone Health dimostra l’esistenza di una vera e […] L'articolo “Prima era solo un sospetto, ora c’è la conferma. Ozempic, Wegovy e i farmaci dimagranti aumentano la perdita dei capelli,...

26. Tue, 8 September 2026

    1 report
    • femalefirst.co.uk12:00
      Weight-loss jabs could cut asthma attacks

      Weight loss jabs could slash the risk of asthma attacks by almost 40 per cent, raising hopes the drugs could offer benefits beyond helping people shed pounds.

27. Wed, 9 September 2026

    2 reports
    • Google News - Top Stories11:00
      Weight regain after obesity drugs tied to higher odds of suicidal thoughts in observational study

      Weight regain after obesity drugs tied to higher odds of suicidal thoughts in observational study Fox News

    • Google News - Top Stories16:10
      Scientists Found a Surprising Effect of Ozempic. It Involves Your Lungs

      Scientists Found a Surprising Effect of Ozempic. It Involves Your Lungs Gizmodo Semaglutide Linked To 40% Fewer Asthma Attacks U.S. News & World Report Asthma, COPD Attacks Down With GLP-1 Drugs in the Picture MedPage Today Ozempic and Wegovy linked to nearly 40% fewer asthma attacks Science Daily New study links GLP-1 ingredient to decrease in asthma attacks, COPD flare-ups KSBY News

28. Thu, 10 September 2026

    2 reports
    • Wirtualna Polska (Poland)13:22
      Lek na otyłość wydłuża życie. Efekt większy niż przy ograniczeniu kalorii

      Semaglutyd, popularny lek z grupy analogów GLP-1 stosowany m.in. w cukrzycy typu 2 i otyłości, wydłużał życie starszych myszy i poprawiał ich funkcje poznawcze oraz mięśniowe. Wyniki badania opublikowanego w "Nature" sugerują też korzyści szersze niż te uzyskane wyłącznie przez ograniczenie kalorii w diecie.

    • meddeviceonline.com18:15
      Engineering Medical Devices To Improve Oral Delivery Of Biopharmaceuticals

      Two approved GLP-1 pills validated the demand — and exposed the ceiling that only delivery devices can break.

29. Sun, 13 September 2026

    2 reports
    • Google News - Top Stories17:00
      Popular GLP-1 weight-loss drugs linked to potentially deadly brain disorder

      Popular GLP-1 weight-loss drugs linked to potentially deadly brain disorder Fox News See more headlines & perspectives on Google News

    • ABC News (Australia)20:01edited after publishing
      Fresh warning after peptide user suffers torn oesophagus

      previouslyPatient suffers torn oesophagus after using unapproved peptide

      The medicines regulator reveals a patient suffered a torn oesophagus after using an unapproved weight-loss peptide labelled as retatrutide.

30. Mon, 14 September 2026

    2 reports
    • The Guardian World02:41
      Peptide user tore oesophagus after using counterfeit product, Australian regulator warns

      TGA issues alert after person was hospitalised after believing they were taking experimental weight loss drug retatrutide Follow our Australia news live blog for latest updates Get our breaking news email , free app or daily news podcast A patient who tore their oesophagus after taking a counterfeit version of an experimental weight loss drug has prompted Australia’s medicines regulator to warn of serious risks of such products. The concern relates to retatrutide, a type of drug known as a...

    • The Hill17:34
      GLP-1-driven vitamin deficiency linked to rare brain disorder: Study

      Researchers found a rare but potentially life-threatening brain disorder in a small number of people taking Ozempic, Wegovy and similar drugs.

31. Tue, 15 September 2026

    2 reports
    • prnewswire.com10:45
      Lilly to present new data on Foundayo, retatrutide, and eloraTZP at EASD 2026, as it strives to change the course of cardiometabolic health

      URL changednow www.prnewswire.com:443/news-releases/lilly-to-present-new-data-on-foundayo-retatrutide-and-eloratzp-at-easd-2026-as-it-strives-to-change-the-course-of-cardiometabolic-health-302878341.html

      Pivotal results from TRIUMPH-2 showed retatrutide, an investigational triple hormone receptor agonist, delivered substantial weight loss and A1C improvements...

    • menshealth.com19:29
      Are GLP-1s the New Statins?

      Cardiologists are working the weight-loss drugs into more patient conversations.

32. Wed, 16 September 2026

    1 report
    • endocrinologyadvisor.com19:18
      FIERCE Pharma 2026: Cultural Stigma, Misinformation May Contribute to Avoidance of GLP-1 RAs

      Cultural stigma and sensationalized media narratives regarding GLP-1 RAs contribute to patient drug avoidance and treatment nonadherence.

33. Thu, 17 September 2026

    1 report
    • ABC (Spain)23:21
      Salena Sainz, farmacéutica: «El GLP-1 es la hormona que fabrica tu cuerpo y ayuda de forma natural a quitarte el hambre»

      GLP-1. Hasta hace poco era un término prácticamente desconocido, pero ante el auge de los medicamentos utilizados para adelgazar, últimamente ha crecido el interés por conocer esta hormona natural por sus grandes beneficios. «El GLP-1 no es un fármaco , sino una hormona que produce nuestro propio intestino y que interviene en la saciedad, la regulación de la glucosa y el metabolismo. Los fármacos simplemente imitan su acción», apunta Salena Sainz, farmacéutica y nutricionista especializada en...

34. Fri, 18 September 2026

    2 reports
    • livemint.com08:33
      When weight loss isn’t the goal of taking a GLP-1

      Doctors are exploring whether weight-loss drugs could also treat conditions such as endometriosis and Crohn’s disease.

    • South China Morning Post11:21
      Thailand makes weight-loss pens prescription-only to counter glut of illegal medicines

      Thailand has moved to make weight-loss pens prescription-only, as a glut of the GLP-1 medicines – which mimic the hormones released once someone is full – floods the black market and influencers swarm TikTok to extol the quick wins of the simple injections. The Southeast Asian nation, which is never far behind wellness or aesthetic trends and has a notorious black market in counterfeit drugs, has seen the uptake of GLP-1 medicines skyrocket, doctors say, including the market-leading Ozempic...

35. Mon, 21 September 2026

    5 reports
    • Google News - Top Stories15:14
      JB Pritzker reveals GLP-1 use and 80-pound weight loss, pressed on possible presidential run

      JB Pritzker reveals GLP-1 use and 80-pound weight loss, pressed on possible presidential run CBS News JB Pritzker Says He Used GLP-1s to Lose 80 Pounds The New York Times Ahead of Possible Presidential Bid, JB Pritzker Says He Is Taking Weight-Loss Drugs WSJ Illinois Gov. JB Pritzker says he has lost 80 pounds on ‘life-changing’ GLP-1 medication CNN Pritzker says he’s lost 80 pounds on GLP-1 since diabetes diagnosis Politico

    • Google News - Top Stories16:28
      JB Pritzker Says He Used GLP-1s to Lose 80 Pounds

      JB Pritzker Says He Used GLP-1s to Lose 80 Pounds The New York Times Ahead of Possible Presidential Bid, JB Pritzker Says He Is Taking Weight-Loss Drugs WSJ Sizing up a 2028 bid, he used a weight-loss drug to drop 80 pounds The Seattle Times Illinois Gov. JB Pritzker says he has lost 80 pounds on ‘life-changing’ GLP-1 medication CNN Pritzker says he’s lost 80 pounds on GLP-1 since diabetes diagnosis Politico

    • The Hill17:11
      Pritzker says he's lost 80 pounds on GLP-1: 'I've been driven my whole life to lose weight'

      Illinois Gov. JB Pritzker (D) said in a new interview that he has dropped 80 pounds using a GLP-1 drug. “I have been driven my whole life to lose weight,” Pritzker said in an interview that aired Monday on “CBS Mornings.” “The fact that I am now able to do it because this GLP-1 became...

    • northernpublicradio.org20:13
      Gov. Pritzker opens up about his 80 lb. weight loss, use of GLP-1 — ‘I think it’s what I need to succeed’

      More than two years into his new weight loss journey, JB Pritzker says he wants to talk about it openly, largely in part because he knows millions of Americans are suffering from obesity-related health conditions. The disclosure also comes just months before Democrats are expected to announce their intentions to run for president.

    • fox4news.com22:07
      GLP-1 drugmakers sued over sudden vision loss risk: Reports

      A civil lawsuit has been filed against GLP-1 drugmakers over the potential risk of sudden vision loss, according to multiple reports.

36. Tue, 22 September 2026

    10 reports
    • Google News - Top Stories03:30
      The dangerous risks of stopping Ozempic and GLP-1s

      The dangerous risks of stopping Ozempic and GLP-1s Axios Stopping Ozempic may raise heart attack and stroke risk ScienceDaily The deadly risk of STOPPING fat jabs revealed – as 2 killers can strike up to 2 years later The Sun

    • Google News - Europe query06:21
      Novo regains GLP-1 market share in Europe and Canada, executive says - medwatch.com

      Novo regains GLP-1 market share in Europe and Canada, executive says medwatch.com

    • iheart.com12:18
      Pritzker Reveals His Use Of GLP-1 Weight Loss Drug

      Illinois Governor JB Pritzker reveals his 80-pound weight loss with GLP-1 medication after a Type 2 diabetes diagnosis. His health transformation, aided by diet and exercise, has eliminated his need for insulin. Pritzker's focus remains on Illinois, despite speculation about a 2028 presidentia...

    • iheart.com12:18
      Pritzker Reveals His Use Of GLP-1 Weight Loss Drug

      Illinois Governor JB Pritzker reveals his 80-pound weight loss with GLP-1 medication after a Type 2 diabetes diagnosis. His health transformation, aided by diet and exercise, has eliminated his need for insulin. Pritzker's focus remains on Illinois, despite speculation about a 2028 presidentia...

    • iheart.com12:18
      Pritzker Reveals His Use Of GLP-1 Weight Loss Drug

      Illinois Governor JB Pritzker reveals his 80-pound weight loss with GLP-1 medication after a Type 2 diabetes diagnosis. His health transformation, aided by diet and exercise, has eliminated his need for insulin. Pritzker's focus remains on Illinois, despite speculation about a 2028 presidentia...

    • iheart.com12:18
      Pritzker Reveals His Use Of GLP-1 Weight Loss Drug

      Illinois Governor JB Pritzker reveals his 80-pound weight loss with GLP-1 medication after a Type 2 diabetes diagnosis. His health transformation, aided by diet and exercise, has eliminated his need for insulin. Pritzker's focus remains on Illinois, despite speculation about a 2028 presidentia...

    • iheart.com12:18
      Pritzker Reveals His Use Of GLP-1 Weight Loss Drug

      Illinois Governor JB Pritzker reveals his 80-pound weight loss with GLP-1 medication after a Type 2 diabetes diagnosis. His health transformation, aided by diet and exercise, has eliminated his need for insulin. Pritzker's focus remains on Illinois, despite speculation about a 2028 presidentia...

    • Al Jazeera English15:23
      Can GLP-1 drugs like Ozempic cause vision loss? What we know about the risk

      More than 90 lawsuits against GLP-1 companies claim rare eye condition resulted from diabetes and weight loss drugs.

    • kbtx.com20:47
      Hundreds of lawsuits allege GLP-1s like Ozempic, Wegovy and Mounjaro caused permanent vision loss

      Lawsuits against GLP-1 makers Eli Lilly and Novo Nordisk allege Ozempic, Wegovy, Mounjaro and other drugs caused NAION and vision loss.

      1 reprint

      • acadiananewsfirst.com22 Sept, 20:47their copy
    • tportal (Croatia)21:58
      Hrvati nakon Ozempica prijavili smetnje vida, moguća i sljepoća: 'Stanje je nepovratno'

      Sve više ljudi koristi lijekove za mršavljenje, no uz njihov rastući uspjeh stižu i prijave ozbiljnih nuspojava. U SAD-u je u jedinstveni savezni postupak objedinjeno 216 tužbi zbog navodnog oštećenja vida, a smetnje su zabilježene i među hrvatskim pacijentima.

37. Wed, 23 September 2026

    2 reports
    • ČT24 (Czechia)11:17
      Šestina amerických dětí užívajících léky proti obezitě trpí nedostatkem živin

      Léky jako Ozempic nebo Wegovy, tedy přípravky na bázi GLP-1, zásadně změnily to, jak se léčí obezita. Po celém světě se ukazuje, že umí zásadně snížit hmotnost u lidí, kterým nepomáhají žádné jiné metody. A několik let se už také nasazují na léčbu dětí. Nová americká studie ale ukazuje, že právě u dětí by lékaři měli začít dávat více pozor.

    • Dnevnik.hr (Croatia)11:30
      Popularni lijek koji se koristi i za mršavljenje odsad preko HZZO-a
38. Thu, 24 September 2026

    1 report
    • premiumtimesng.com15:55
      US patients sue Ozempic, Mounjaro makers over vision loss

      The development comes as GLP-1 medicines become increasingly available in Nigeria, where a recent PREMIUM TIMES investigation found that the injections were being sold online without prescriptions or evidence of medical supervision.

39. Fri, 25 September 2026

    1 report
    • Slobodna Dalmacija (Croatia)06:52
      Uzimate lijekove za mršavljenje? Znanstvenici otkrili velike rizike od neugodne i potencijalno opasne komplikacije

      Lijekovi iz skupine GLP-1, među kojima su Ozempic, Wegovy i Mounjaro, posljednjih su godina postali iznimno popularni u liječenju dijabetesa i pretilosti. Novo veliko istraživanje iz Ujedinjenog Kraljevstva sada je pokazalo da bi njihova primjena mogla biti povezana s povećanim rizikom od regurgitac...

40. Sun, 27 September 2026

    1 report
    • fox5dc.com13:48
      Doctor warns of potential interactions between GLP-1 drugs and cannabis

      A physician and cannabinoid specialist is sounding the alarm on the potential interactions between cannabis and GLP-1s for a small percentage of people who use both.

41. Mon, 28 September 2026

    1 report
    • aol.com11:00
      Popular weight-loss drugs can become an ‘atomic bomb’ at high doses, doctor warns

      Dr. Will Cole warns that macro-dosing GLP-1s isn't the answer to metabolic health, advocating for micro-dosing peptides paired with lifestyle changes.

42. Tue, 29 September 2026

    4 reports
    • medscape.com00:00
      Obesity Drug Users in Structured Program Lost Mostly Fat

      Patients receiving incretin-based obesity drugs and supervised exercise and nutritional support lost mostly fat, with no statistically significant change noted in lean mass.

    • prnewswire.com07:00
      Lilly's Foundayo (orforglipron) 17.2 mg showed greater weight loss and A1C reduction than oral semaglutide 25 mg among adults with type 2 diabetes in a new indirect treatment comparison

      /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide), today announced results from a new analysis showing that Foundayo...

    • Telegram.hr (Croatia)10:54
      Ljudi koji uzimaju GLP-1 lijekove često to skrivaju zbog straha od osude: ‘Nazivaju nas varalicama’

      Ove lijekove uzimaju u tajnosti i iz straha da će ih drugi optužiti da su odabrali "lakši put"

    • Anadolu Agency (AA)11:39
      China's Hengrui licenses weight-loss drug to Denmark's Novo Nordisk in deal worth up to $2.6B

      Experimental once-weekly oral drug designed to reduce weight, improve blood sugar control

43. Wed, 30 September 2026

    5 reports
    • Google News - Top Stories14:15
      Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial

      Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial CNBC People with Type 2 diabetes lost up to 60 pounds on Lilly’s latest weight loss drug NBC News ‘Godzilla’ of weight-loss drugs could provide other important health benefits The Guardian Blockbuster retatrutide trial signals a ‘new high-water mark’ for weight-loss drugs Scientific American Most powerful obesity drug yet: People lost up to 25% of weight in trial Ars Technica

    • Vecernji list (Croatia)14:54
      Sve više prijava nuspojava od lijekova za mršavljenje, rijetke se mogu otkriti tek u široj primjeni

      Činjenica je i da velik broj ljudi ove lijekove – ili ono što se prodaje pod njihovim nazivima – nabavlja "na crno", bez prethodnih liječničkih pretraga i liječničkog nadzora, što je suprotno liječničkim uputama

    • bdnews24.com15:08
      'Godzilla' weight-loss drug shows big results in largest trial of its kind
    • ABC News (Australia)18:54
      Big pharma move to dispense GLP-1s to your door condemned by doctors

      Doctors and pharmacists have criticised Eli Lilly's new online platform LillyDirect that will dispense certain medicines, starting with Mounjaro, directly to a patient's door.

    • everydayhealth.com20:36
      Weight Loss Continues After Switching From a GLP-1 Shot to a Pill, Study Finds

      Newly presented research suggests that moving from a GLP-1 injectable to a pill continues weight loss. Doctors aren’t shocked.

44. Thu, 1 October 2026

    1 report
    • aol.com18:10
      How GLP-1s are rewiring the doctor-patient relationship

      Zocdoc reports that GLP-1 prescriptions enhance the doctor-patient relationship, prompting more follow-up care and holistic health engagement beyond weight loss.

45. Fri, 2 October 2026

    3 reports
    • Le Monde English02:49
      Galderma, Switzerland's discreet Botox empire

      The dermatology company's market capitalization has doubled since its initial public offering in 2024. Despite recurring scandals, botulinum toxin injections are expected to rake in $13 billion this year.

    • healthline.com10:00
      2026 Healthline Survey: GLP-1 Expectations vs. Personal Experiences

      The Survey explores expectations vs. real-world experiences when it comes to GLP-1 weight loss results, side effects, and treatment duration, among other common concerns.

    • Google News - Top Stories15:13
      Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s - cnbc.com

      Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s cnbc.com Experimental Lilly combination drug tops Zepbound in weight-loss trial Reuters ‘Godzilla’ of weight-loss drugs could provide other important health benefits The Guardian Lilly sets up next-gen obesity battle with full phase 3 retatrutide data Fierce Biotech 3 takeaways from a European obesity scientific meeting BioPharma Dive

46. Sat, 3 October 2026

    3 reports
    • Google News - Top Stories01:02
      Ozempic Rival Delivers 25% Weight Loss at Highest Dose in Phase 3 Trial

      Ozempic Rival Delivers 25% Weight Loss at Highest Dose in Phase 3 Trial ScienceAlert Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s CNBC Blockbuster retatrutide trial signals a ‘new high-water mark’ for weight-loss drugs Scientific American ‘Godzilla’ of weight-loss drugs could provide other important health benefits The Guardian Lilly raises diabetes weight-loss bar with amylin-Zepbound combo Fierce Biotech

    • Le Monde (France)12:00
      « L’arrivée des médicaments antiobésité en France ne permet pas de prédire la disparition de la grossophobie »

      Le Wegovy et le Mounjaro sont, depuis juin, remboursés sous conditions par l’Assurance-maladie. L’anthropologue Ghislaine Gallenga craint, dans une tribune au « Monde », que cette avancée thérapeutique n’ajoute à la culpabilisation des personnes qui n’auront pas perdu de poids, alors qu’un traitement est disponible.

    • Google News - Top Stories13:32
      New study suggests possible connection between GLP-1s and hair loss in men

      New study suggests possible connection between GLP-1s and hair loss in men The Washington Post Study explores genetic link between GLP-1 drugs and male pattern hair loss ABC30 Fresno Nail detachment over four times more common among GLP-1 users, first controlled study finds Medical Xpress Experts have found an unexpected side-effect of weight-loss drugs BBC Science Focus Magazine Hair Loss Was Just the Start. Ozempic Users Are Also Reporting Nail Trouble Gizmodo

47. Sun, 4 October 2026

    1 report
    • Google News - Top Stories22:00
      In early clinical trial, people with Type 1 diabetes are able to go off insulin

      In early clinical trial, people with Type 1 diabetes are able to go off insulin NBC News Could breakthrough new treatment cure Type 1 diabetes? Yahoo Engineered Stem Cell Therapy Reverses New-Onset T1D in Mice by Reprogramming T Cells Pharmacy Times

48. Mon, 5 October 2026

    3 reports
    • derbytelegraph.co.uk09:02
      Weight loss jabs linked to hair loss and nail problems new study finds

      A new study has found that popular weight-loss and diabetes medications may be associated with an increased risk of hair loss and nail issues

      1 reprint

      • coventrytelegraph.net5 Oct, 08:58their copy
    • Google News - Top Stories12:02
      Scientists uncover a clue that could hint at why we regain weight after diets

      Scientists uncover a clue that could hint at why we regain weight after diets The Washington Post Obesity’s Epigenetic ‘Memory’ Fuels Weight Regain Medscape Scientists Find A Molecular Clue That Could Explain Why Weight Comes Back Yahoo Scientists, Led By Indian American, identify biological mechanism that may explain obesity relapse News India Times

    • PBS NewsHour22:30
      As GLP-1s reshape America, questions and new uses emerge

      Hailed by some as miracle drugs, GLP-1s have surged in popularity in the past few years. An estimated one out of every eight Americans is now on some version of them and scientists continue to research new potential uses. But with that rapid expansion, there's a growing list of questions and skeptics. William Brangham reports for our new series, GLP-1s: Reshaping America.

49. Tue, 6 October 2026

    3 reports
    • ukiahdailyjournal.com14:10
      ‘Not a miracle drug’: GLP-1 meds not effective without plan, exercise

      Alan Zellner, 76, had concerns about taking an unfamiliar medication. But, faced with rising blood pressure and an expanding waistline, he followed the advice of doctors and began taking Ozempic.

    • ABC News (Australia)18:00
      Patients hiding use of peptides or weight loss jabs face 'serious' surgery risk

      Patients hiding the use of illegal peptides or weight loss jabs before surgery could face "serious" consequences, after a new study reveals an 11-fold risk of regurgitation or aspiration under anaesthetic.

    • PBS NewsHour22:20
      High cost of GLP-1s drives some to seek cheaper, unregulated versions

      Despite some recent improvements, millions of Americans still face significant barriers in affording GLP-1s. At the same time, many patients have found alternative, cheaper paths to get their hands on unregulated versions. Stephanie Sy reports for our series, GLP-1s: Reshaping America.

50. Wed, 7 October 2026

    2 reports
    • somersetlive.co.uk05:43
      Adverts for weight loss pills 'first to be banned'

      Pharmacies have been inviting people to join waiting lists, register their interest and pre-order treatment.

    • PBS NewsHour22:30
      The evidence suggesting GLP-1s can curb drug and alcohol cravings

      A growing body of evidence suggests that GLP-1 drugs are not only helping millions with their diabetes and weight loss, but they're also proving effective at curbing people's desire for drugs and alcohol. William Brangham reports on the researchers who are testing whether these medications can help tackle the country's addiction crisis. It's part of our series, GLP-1s: Reshaping America.

51. Thu, 8 October 2026

    1 report
    • PBS NewsHour22:25
      How GLP-1s are reshaping cultural views on body image

      About 12% of Americans are now taking the blockbuster set of weight-loss medications known as GLP-1s. While their popularity continues to skyrocket, new concerns have emerged around the societal impacts these drugs are having, especially around body image. Stephanie Sy and producers Mike Fritz and Sam Lane have the story for our series, GLP-1s: Reshaping America.

52. Fri, 9 October 2026

    5 reports
    • Index.hr (Croatia)05:35
      Istraživanje: Gotovo 40% korisnika GLP-1 lijekova prijavilo otpadanje noktiju

      NOVO istraživanje ukazuje na povezanost GLP-1 lijekova za dijabetes i pretilost s češćim problemima noktiju i ispadanjem kose, no uzročna veza još nije dokazana. Potrebna su daljnja istraživanja.

    • Le Monde (France)12:30
      Médicaments antiobésité : la ruée des patients met le système de soins français en surchauffe

      Le remboursement, sous conditions, du Wegovy et du Mounjaro, depuis le 15 juin, a eu pour effet un bond des demandes de prise en charge par les centres spécialisés dans l’obésité. Le phénomène révèle l’ampleur de l’obésité sévère en France et les difficultés à assurer le suivi des patients.

    • cosmopolitan.com17:15
      “Diet And Exercise Alone Weren’t Enough For Me To Lose Weight—Here’s What Helped Me”

      This mother of two lost weight by adding a weight-management medication to her lifestyle alongside reducing calorie intake and increasing exercise.

    • gizmodo.com19:45
      Your Ozempic Prescription May Come With a Surprising Bonus: Slower Aging

      Recent data from Novo Nordisk and Eli Lilly suggests GLP-1s can noticeably slow down people's molecular aging clocks.

    • The Guardian World23:00edited after publishing
      Women with PMOS should get subsidised weight-loss drugs, Australian advocates say

      previouslyWomen with PMOS should get subsidised weight loss drugs, advocates say

      With GLP-1s to treat the condition not specifically approved by the TGA, patients are being prescribed them off-label Get our breaking news email , free app or daily news podcast Women living with a chronic hormonal condition should have access to taxpayer-funded weight-loss medications, advocates say. The Polyendrocrine Metabolic Ovarian Syndrome Association of Australia (POSAA) is urging for GLP-1 drugs to be approved on the Pharmaceutical Benefits Scheme for people living with the condition....

53. Sat, 10 October 2026

    3 reports
    • NPR News11:00
      Ongoing lawsuits allege GLP-1s can cause serious harm. But we don't know how often

      Scant data about serious adverse effects makes it harder to answer scientific and legal questions about how often the drugs might cause serious harm like blindness or pancreatitis.

      4 reprints

      • waer.org10 Oct, 11:00their copy
      • wysu.org10 Oct, 11:00their copy
      • apr.org10 Oct, 11:00their copy
      • ksfr.org10 Oct, 11:00their copy
    • Le Figaro (France)16:00
      «Après six mois de traitement sous Ozempic, je ne bois quasiment plus» : les médicaments anti-obésité vont-ils précipiter la chute du vin ?

      Aux États-Unis, un adulte sur huit prend un analogue du GLP-1, et une partie d’entre eux admet avoir vu son envie de boire baisser drastiquement. Si des essais cliniques confirment un effet sur l’alcool chez certains patients, faut-il y voir une menace pour le marché du vin ?

    • iDNES (Czechia)19:00
      Méně jídla, menší útraty. Léky na hubnutí přepisují pravidla americké gastronomie

      Rozmach přípravků na hubnutí, jako je například Wegovy, Ozempic anebo Zepbound, zasahuje také americké restaurace. Hosté jedí méně a častěji si nechávají jídlo zabalit. Podniky proto hledají způsob, jak se jejich novým stravovacím návykům přizpůsobit.

54. Sun, 11 October 2026

    1 report
    • dailypost.co.uk09:41
      New weekly weight loss jab may cut belly fat and help shed pounds

      Survodutide clinical trial results show the medication may cut fat around the internal organs and in the liver

55. Mon, 12 October 2026

    1 report
    • dailystar.co.uk08:32
      Beer bellies could go extinct as boffs find fat jab targets alcohol-induced gut

      Science has found a fat jab that is said to target visceral fat – the causer of beer guts – in users. The development means protruding round guts may soon be a thing of the past

56. Tue, 13 October 2026

    2 reports
    • Google News - Top Stories10:00
      Could GLP-1 drugs be anti-aging medications?

      Could GLP-1 drugs be anti-aging medications? CNN GLP-1 weight-loss drugs slow biological aging, recent studies show NewsNation Your Ozempic Prescription May Come With a Surprising Bonus: Slower Aging Gizmodo Can GLP-1s Slow Aging? Nautilus | Science Connected GLP-1 Drugs May Slow Aging By Upto Four Years, Early Research Suggest RTTNews

    • kxxv.com17:25
      Could GLP-1 drugs be anti-aging medications?

      GLP-1 medications for weight loss and diabetes appear to slow the body’s aging processes, a sign that the blockbuster drugs could ultimately help people live longer.

      1 reprint

      • wkbw.com13 Oct, 17:25their copy
57. Wed, 14 October 2026

    1 report
    • gizmodo.com15:50
      The Most Powerful Weight Loss Drug Yet Isn’t Approved, but Its Black Market May Already Be Turning Deadly

      Though retatrutide isn't approved anywhere yet, some companies are already widely distributing and selling it alongside other unregulated peptides.

58. Thu, 15 October 2026

    1 report
    • Google News - Top Stories11:00
      Man claims he went blind after taking Ozempic, shares warning for other users

      Man claims he went blind after taking Ozempic, shares warning for other users Fox News Ozempic and Wegovy linked to rare risk of sudden vision loss Science Daily No Effect of GLP-1s on Anti-VEGF Injection Frequency for Diabetic Macular Edema MedPage Today Attorney Tracy Paulsen Brings Focused Experience to Growing GLP-1 Vision Loss and NAION Litigation StreetInsider US study links GLP-1 drugs to rare vision loss — ScienceDaily UA.NEWS

59. Fri, 16 October 2026

    3 reports
    • dairyreporter.com00:00
      What do GLP-1 users want to eat and drink when they’re out?

      GLP-1 users must have their needs met outside the home. Here's how foodservice and snacks can adapt with smaller portions, protein-rich options and smarter menus.

    • pharmacytimes.com04:17
      Tirzepatide Linked to More Weight Loss Than Semaglutide 7.2 mg

      A new analysis finds a significant weight loss edge for tirzepatide under one estimand but not another; no head-to-head trial exists at these doses.

    • sowetan.co.za13:28
      Weight-loss drugmakers race for slice of $100bn pie

      Pills, monthly injections and novel combinations drive fierce innovation in obesity drugs

60. Sat, 17 October 2026

    1 report
    • El Mundo (Spain)22:45
      Alimentos 'GLP-1 friendly': cuando el marketing va tras el medicamento

      La industria alimentaria pretende subirse a la ola levantada por los fármacos de la 'familia Ozempic', pero esa etiqueta estampada en algunos envases no tiene respaldo científico Leer

61. Mon, 19 October 2026

    3 reports
    • Slobodna Dalmacija (Croatia)08:32
      Uzimali su Ozempic, pa prestali i sada imaju užasne nuspojave: ‘Čak pedeset posto njih ima ove simptome‘

      Nova studija otkrila je da lijekovi koji se koriste za liječenje dijabetesa tipa 2 i pretilosti iz skupine agonista GLP-1 receptora, u koju spadaju Ozempic i Wegovy, mogu biti povezani s problemima s noktima i kosom. Istraživači su otkrili da su korisnici ovih lijekova imali veću vjerojatnost da će...

    • dailykos.com11:00
      Diabetes News: Retatrutide for Diabetes and Weight Loss

      Some of my friends say that they love living in the future, and here it is again. We have several diabetes medicines that turned out to be good for weight loss and other medical issues…

    • manilatimes.net12:06
      Rivus Pharmaceuticals to Present Preclinical Obesity Data for Muscle-Preserving, Oral GLP-1 RV-8451 at ObesityWeek®

      CHARLOTTESVILLE, Va., and SOUTH SAN FRANCISCO, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Rivus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on advancing cardiometabolic health, today announced the presentation of preclinical NHP obesity data from RV-8451, a novel, muscle-preserving, oral small molecule GLP-1 receptor agonist at The Obesity Society’s 44th Annual Meeting at ObesityWeek® 2026 being held November 14-17, 2026 in Washington, DC.

62. Tue, 20 October 2026

    1 report
    • nzherald.co.nz01:53
      Rise of GLP-1 good news for New Zealand farmers and growers

      GLP-1 drugs drive demand for New Zealand protein and premium fruit.